ZS Pharma Surges 50 Percent In IPO

Fort Worth-based ZS Pharma is up dramatically in its IPO today, trading as high as $28.11 per share in mid-day trading after debuting at $18.00 per share this morning. The company--which priced last night above its initial estimated IPO range of $15.00 and $17.00--develops treatments for patients with kidney and liver disease. ZS Pharma is backe dby Alta Partners, Devon Park Bioventures, 3x5 Special Opportunity Partners, Salem Partners, and RiverVest Venture Partners. The company was up more than 50% on the markets after the IPO.